Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (3,315)

Search Parameters:
Keywords = pathology image

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 3572 KiB  
Article
Ex Vivo Fusion Confocal Microscopy of Liver Biopsies: Diagnostic Pattern Identification and Correlation with Conventional Microscopy
by Sandra Lopez-Prades, Carla Fuster-Anglada, Rosana Millán, Joana Ferrer-Fàbrega, Octavi Bassegoda, Loreto Boix, Miriam Cuatrecasas and Alba Díaz
Appl. Sci. 2024, 14(23), 11121; https://doi.org/10.3390/app142311121 (registering DOI) - 28 Nov 2024
Abstract
Ex vivo Fusion Confocal Microscopy (eFuCM) is a promising new technique for real-time histological diagnosis, requiring minimal tissue preparation and avoiding tissue waste. This study aimed to evaluate the feasibility of eFuCM in identifying key liver biopsy lesions and patterns, and to assess [...] Read more.
Ex vivo Fusion Confocal Microscopy (eFuCM) is a promising new technique for real-time histological diagnosis, requiring minimal tissue preparation and avoiding tissue waste. This study aimed to evaluate the feasibility of eFuCM in identifying key liver biopsy lesions and patterns, and to assess the impact of eFuCM reading experience on diagnostic accuracy. Twenty-three fresh liver biopsies were analyzed using eFuCM to produce H&E-like digital images, which were reviewed by two pathologists and compared with a conventional H&E diagnosis. The liver architecture was clearly visible on the eFuCM images. Pathologist 1, with no prior eFuCM experience, achieved a substantial agreement with the H&E diagnosis (κ = 0.65), while Pathologist 2, with eFuCM experience, reached almost perfect agreement (κ = 0.88). However, lower agreement levels were found in the evaluation of inflammation. Importantly, tissue preparation for eFuCM did not compromise subsequent conventional histological processing. These findings suggest that eFuCM has great potential as a time- and material-saving tool in liver pathology, though its diagnostic accuracy improves with pathologist experience, indicating that there is a learning curve related to its use. Full article
12 pages, 1899 KiB  
Article
Image Biomarker Analysis of Ultrasonography Images of the Parotid Gland for Baseline Characteristic Establishment with Reduced Shape Effects
by Hak-Sun Kim
Appl. Sci. 2024, 14(23), 11041; https://doi.org/10.3390/app142311041 - 27 Nov 2024
Viewed by 246
Abstract
Background: This study aimed to analyze image biomarkers of the parotid glands in ultrasonography images with reduced shape effects, providing a reference for the radiomic diagnosis of parotid gland lesions. Methods: Ultrasound (US) and sialography images of the parotid glands, acquired from September [...] Read more.
Background: This study aimed to analyze image biomarkers of the parotid glands in ultrasonography images with reduced shape effects, providing a reference for the radiomic diagnosis of parotid gland lesions. Methods: Ultrasound (US) and sialography images of the parotid glands, acquired from September 2019 to March 2024, were reviewed along with their clinical information. Parotid glands diagnosed as within the normal range were included. Overall, 91 US images depicting the largest portion of the parotid glands were selected for radiomic feature extraction. Regions of interest were drawn twice on 50 images using different shapes to assess the intraclass correlation coefficient (ICC). Feature dimensions were statistically reduced by selecting features with an ICC > 0.8 and applying four statistical algorithms. The selected features were used to distinguish age and sex using the four classification models. Classification performance was evaluated using the area under the receiver operating characteristic curve (AUC), recall, and precision. Results: The combinations of the information gain ratio algorithm or stochastic gradient descent and the naïve Bayes model showed the highest AUC for both age and sex classification (AUC = 1.000). The features contributing to these classifications included the first-order and gray-level co-occurrence matrix (high-order) features, particularly discretized intensity skewness and kurtosis, intensity skewness, and GLCM angular second moment. These features also contributed to achieving one of the highest recall (0.889) and precision (0.926) values. Conclusions: The two features were the most significant factors in discriminating radiomic variations related to age and sex in US images with reduced shape effects. These radiomic findings should be assessed when diagnosing parotid gland pathology versus normal using US images and radiomics in a heterogeneous population. Full article
(This article belongs to the Section Applied Dentistry and Oral Sciences)
Show Figures

Figure 1

Figure 1
<p>Schematic diagram illustrating the flow of the study. ROI, region of interest; ICC, intraclass correlation coefficient; ROC, receiver-operating characteristic.</p>
Full article ">Figure 2
<p>Examples of ultrasound images of parotid glands: (<b>a</b>) a normal parotid gland with homogeneous echogenicity, included in the study; and (<b>b</b>) an inflammatory parotid gland showing heterogeneous echogenicity with numerous hypoechoic foci, excluded from the study.</p>
Full article ">Figure 3
<p>Examples of regions of interest selection in an ultrasound image of a parotid gland: (<b>a</b>) polygonal, (<b>b</b>) square shape.</p>
Full article ">Figure 4
<p>Performance metrics for four statistical algorithms and four classification models: (<b>a</b>–<b>c</b>) area under the receiver operating characteristic curve results, (<b>d</b>–<b>f</b>) recall, and (<b>g</b>–<b>i</b>) precision. Metrics are presented for (<b>a</b>,<b>d</b>,<b>g</b>) age, (<b>b</b>,<b>e</b>,<b>h</b>) sex, and (<b>c</b>,<b>f</b>,<b>i</b>) combined age and sex classification. The highest scores are highlighted in bold. AUC, area under the receiver operating characteristic curve; LASSO, least absolute shrinkage and selection operator; IGR, information gain ratio; SGD, stochastic gradient descent; KNN, k-nearest neighbors.</p>
Full article ">Figure 5
<p>Confusion matrices showing the classification results for each combination of statistical algorithm and machine learning model: (<b>a</b>) age, (<b>b</b>) sex, and (<b>c</b>) combined age and sex classification.</p>
Full article ">
22 pages, 25914 KiB  
Review
Imaging in Vascular Liver Diseases
by Matteo Rosselli, Alina Popescu, Felix Bende, Antonella Al Refaie and Adrian Lim
Medicina 2024, 60(12), 1955; https://doi.org/10.3390/medicina60121955 - 27 Nov 2024
Viewed by 278
Abstract
Vascular liver diseases (VLDs) include different pathological conditions that affect the liver vasculature at the level of the portal venous system, hepatic artery, or venous outflow system. Although serological investigations and sometimes histology might be required to clarify the underlying diagnosis, imaging has [...] Read more.
Vascular liver diseases (VLDs) include different pathological conditions that affect the liver vasculature at the level of the portal venous system, hepatic artery, or venous outflow system. Although serological investigations and sometimes histology might be required to clarify the underlying diagnosis, imaging has a crucial role in highlighting liver inflow or outflow obstructions and their potential causes. Cross-sectional imaging provides a panoramic view of liver vascular anatomy and parenchymal patterns of enhancement, making it extremely useful for the diagnosis and follow-up of VLDs. Nevertheless, multiparametric ultrasound analysis provides information useful for differentiating acute from chronic portal vein thrombosis, distinguishing neoplastic invasion of the portal vein from bland thrombus, and clarifying the causes of venous outflow obstruction. Color Doppler analysis measures blood flow velocity and direction, which are very important in the assessment of VLDs. Finally, liver and spleen elastography complete the assessment by providing intrahepatic and intrasplenic stiffness measurements, offering further diagnostic information. Full article
(This article belongs to the Section Gastroenterology & Hepatology)
Show Figures

Figure 1

Figure 1
<p>Acute splanchnic vein thrombosis with extensive involvement of the mesenteric, splenic, and portal venous system. The image provided in (<b>A</b>) shows a transverse section of the liver and spleen on contrast-enhanced CT (CECT) showing thrombosis of the portal venous system (hypodense material filling the vascular lumen, arrowhead). Note is made of complete un-enhancement of the spleen in keeping with subtotal splenic ischemic infarction (arrow). B-mode ultrasound images integrated by directional power doppler show the clot corresponding to hypoechoic material that fills the portal vein, including its intrahepatic bifurcation ((<b>B</b>), arrows). Contrast-enhanced ultrasound reveals a ‘black spleen’ (<b>C</b>) corresponding to the complete absence of intrasplenic residual vascularity seen on CT (<b>A</b>). The patient was immediately commenced on anticoagulation treatment and followed up with sequential imaging. After 2 weeks there is evidence of increased arterial hypertrophy around the clot ((<b>D</b>), arrows) and initial signs of cavernous recanalization as revealed by the evidence of a portal venous flow trace within the clot ((<b>E</b>), arrow). (<b>F</b>) A CECT at 12 months distance revealed cavernous transformation of the portal vein (arrowhead) with good flow. Microvascular imaging and directional power doppler show the portal flow running through a thin fibrin reticulate as a result of the re-canalized thrombus ((<b>G</b>,<b>H</b>), arrows).</p>
Full article ">Figure 2
<p>Acute portal vein thrombosis in a patient with polycythemia rubra vera. (<b>A</b>) Contrast-enhanced CT scan shows a clear sign of partial thrombosis of the extrahepatic portal venous trunk, complete thrombosis of the right anterior portal branch and splenic vein (red arrows). On B-mode ultrasound a clear demarcation of the site of thrombosis can be observed ((<b>B</b>), white arrow). Contrast-enhanced ultrasound (CEUS) shows pronounced hypertrophy of the hepatic artery with arterial buffering revealed by its hyperenhancement on the background of portal hypoperfusion ((<b>C</b>), white arrows), with evidence of thrombosis of the right anterior portal branch ((<b>D</b>), the white arrows highlights the boundary between the thrombosed and patent portal vein). The left portal vein branch is completely thrombosed as shown on CECT ((<b>E</b>) red arrow), B-mode ultrasound ((<b>F</b>,<b>G</b>), white arrows) and CEUS ((<b>H</b>), white arrow). Patency of the right posterior branch of the portal vein is also confirmed on B-mode ((<b>I</b>), white arrow) and CEUS ((<b>I</b>,<b>J</b>), white arrows). There is complete thrombosis of the splenic vein with consequent splenic hypoperfusion ((<b>K</b>,<b>L</b>), white arrows).</p>
Full article ">Figure 3
<p>Months after acute portal vein thrombosis (showed in <a href="#medicina-60-01955-f002" class="html-fig">Figure 2</a>), there is evidence of cavernous transformation of the anterior branch of the right portal vein as it can be seen in both the contrast-enhanced CT scan and directional power Doppler ((<b>A</b>) red arrows, left and right side of the figure, respectively). Pericholecystic varices have also developed ((<b>B</b>), white arrows point to the gallbladder (GB); red arrows point to the pericholecystic varices). Ultrasound microvascular imaging highlights the details of the varicosities ((<b>C</b>), red arrows).</p>
Full article ">Figure 4
<p>Subacute pancreatitis complicated by infected pseudocysts and portal vein thrombophlebitis (pylephlebitis). (<b>A</b>) On contrast-enhanced CT (CECT) the red arrows highlight the infected pseudocysts. Note is made of enhancement of the portal vein walls (arrowhead) and segment VII large hypoperfusional area (black arrow) in the context of which a hypoechoic rounded collection (calipers) is well identified on ultrasound ((<b>B</b>), black arrow). Distal anterior and posterior thrombosed portal venous branches ((<b>B</b>), red arrows). Hypoechoic thrombus is filling the main portal vein with extensive thickening of its walls (<b>C</b>). Multiple reactive lymphadenopathies are also present (red arrows). At one-year from onset portal vein cavernous transformation is seen on both (CECT) ((<b>D</b>), arrowhead) and B-mode ultrasound ((<b>E</b>), red arrow).</p>
Full article ">Figure 5
<p>Patient with abdominal discomfort and a biochemical picture of cholestasis with a previous history of pylephlebitis. Contrast-enhanced CT showed pronounced varicosities compatible with multiple convoluted vascular channels as a result of longstanding portal vein thrombosis with cavernous transformation surrounding dilated bile ducts compatible with portal biliopathy ((<b>A</b>,<b>B</b>) long red arrows). The thrombosed portal vein cannot be visualized and is likely to have undergone fibrotic retraction. The hypodense channel represents the dilated common bile duct ((<b>A</b>,<b>B</b>), short red arrows). The ultrasound images (<b>C</b>) highlight the dilated CBD (short white arrow) surrounded by numerous collaterals from the cavernous transformation (long red arrows).</p>
Full article ">Figure 6
<p>Patient with advanced cirrhosis and diffuse nodularities that enhance in the arterial phase. Of note are the presence of extensive intrahepatic portal vein thromboses that show signs of arterialization on contrast-enhanced CT scan ((<b>A</b>–<b>C</b>), black arrows). Contrast-enhanced ultrasound shows rapid contrast enhancing of the thrombosed portal vein and subsequent washout in the portal and late vascular phase ((<b>D</b>–<b>F</b>), white arrows). The findings of enhancement and washout are compatible with neoplastic invasion of the portal vein.</p>
Full article ">Figure 7
<p>Portal vein thrombosis of the right portal venous branch in a cirrhotic patient and a large downstream heterogeneously perfused area characterized by multiple large pseudonodularities and pronounced arterial buffering. Note is made of intra-thrombotic arterial branching on contrast-enhanced CT and the large dysperfusional area within the right lobe. (<b>A</b>), corresponds to the arterial phase of contrast-enhanced CT and (<b>B</b>), the venous phase. The red arrows point to the right portal venous thrombus. In (<b>C</b>,<b>D</b>), colour and directional power Doppler highlight the presence of the thrombus (white arrows) and the upstream flow before the thrombus (yellow arrow). Note is made of the right hepatic vein (red arrow) that crosses the area without being significantly distorted. If there was neoplastic growth, the hepatic vein would have probably been invaded or displaced, which is not seen in this case. Microvascular imaging highlights microscopic vascularity within the thrombus, making it suspicious for neoplasia ((<b>E</b>) white arrow).</p>
Full article ">Figure 8
<p>Contrast-enhanced ultrasound (CEUS) of the same case presented in <a href="#medicina-60-01955-f007" class="html-fig">Figure 7</a>. An ‘arterialized’ thrombus should always raise the suspicion of ‘neoplastic vascular invasion’. Contrast-enhanced imaging is usually very accurate at showing arterial enhancement with washout in the portal and subsequent late vascular phases in case of neoplastic invasion. However, one of the pitfalls on CEUS is that intra-thrombotic arterialization as a mechanism of pronounced buffering can mimic arterial enhancement of neoplastic tissue invading the portal vein. In fact, no sign of washout is seen in the portal and late vascular phase in this case ((<b>A</b>–<b>D</b>), white arrows). There was no evidence of neoplasia.</p>
Full article ">Figure 9
<p>Longstanding portal vein thrombosis has caused considerable heterogeneity of the liver parenchyma (<b>A</b>,<b>B</b>). Liver stiffness measured by point wave shear wave elastography shows a normal value, ruling out significant fibrosis (<b>B</b>).</p>
Full article ">Figure 10
<p>A patient with Crohn’s disease was found to have a low platelet count and splenomegaly. On MRI with hepatobiliary contrast, splenomegaly can be clearly observed along the longitudinal axis in the coronal plane ((<b>A</b>), white arrow). Note is also made of mild caudate lobe hypertrophy ((<b>B</b>–<b>D</b>) asterisk) and hypotrophy of segment IV ((<b>B</b>), black arrow), which is unusual against a smooth outline. The gallbladder is thickened with fibrotic spiculations ((<b>C</b>), white arrows). The heterogeneous signal intensity of the liver parenchyma is more pronounced around the portal tracts, where it appears hypointense in the portal venous phase. Note is made of an altered caliber of the main portal vein ((<b>D</b>,<b>E</b>), arrowheads)) with numerous narrowed distal portal branches surrounded by a hypointense signal ((<b>D</b>,<b>E</b>), white arrows). In the hepatobiliary phase, note is made of hyperintensity surrounding the portal tracts, which is in keeping with porto-sinusoidal vascular disorder ((<b>F</b>), white arrows).</p>
Full article ">Figure 11
<p>Patient with porto-sinusoidal vascular disorder (PSVD). Note is made of a heterogeneous echotexture with portal vein thickening surrounded by a hypoechoic halo ((<b>A</b>), white arrow). The gallbladder is thickened with a ‘spiculated’ outline in line with portal hypertension and fibrotic-related modifications (<b>B</b>,<b>C</b>). Note is made of a smooth liver outline against the heterogeneous echotexture ((<b>C</b>), arrows). Homogeneous splenomegaly is present; (<b>D</b>); liver stiffness is within normal range ((<b>E</b>), 4.5 kPa) but spleen stiffness is very high ((<b>F</b>), 91 kPa) in keeping with non-cirrhotic clinically significant portal hypertension.</p>
Full article ">Figure 12
<p>Another patient with porto-sinusoidal vascular disorder (PSVD). Note is made of a heterogeneous echotexture with portal vein thickening (<b>A</b>). The gallbladder is thickened with a ‘spiculated’ outline (<b>B</b>). Note is made of a smooth liver outline against the heterogeneous echotexture ((<b>C</b>) arrows). Homogeneous splenomegaly is present (<b>D</b>). Large splenorenal shunt (<b>E</b>). Liver stiffness is within normal range ((<b>F</b>), 5.7 kPa) while spleen stiffness is very high ((<b>G</b>), 92 kPa).</p>
Full article ">Figure 13
<p>Subacute Budd–Chiari syndrome. The liver is enlarged and surrounded by a small amount of ascites ((<b>A</b>), white arrow). The hepatic veins are completely obliterated. The caudate lobe is grossly enlarged, with signs of ischemic infarction ((<b>B</b>), black arrow).</p>
Full article ">Figure 14
<p>Patient with chronic Budd–Chiari. There is a remnant of the right hepatic vein while the other veins are not visible ((<b>A</b>), white arrow). Large caudate lobe hypertrophy and note is made of a transjugular intrahepatic portosystemic shunt (TIPS) in the inferior vena cava ((<b>B</b>), arrow). Multiple small rounded echogenic regenerative nodules are scattered throughout the parenchyma and better highlighted by a high-frequency transducer (<b>C</b>,<b>D</b>). Another case of Budd–Chiari syndrome (<b>E</b>–<b>G</b>). Note is made of small serpiginous intrahepatic veno-venous collaterals ((<b>G</b>), white arrow).</p>
Full article ">Figure 15
<p>FNH-like lesion in a patient with Budd–Chiari syndrome ((<b>A</b>), white arrow). Note the centrifugal arterial enhancement ((<b>B</b>,<b>C</b>)), red arrows) and iso-enhancement in the late vascular phase ((<b>D</b>), red arrows).</p>
Full article ">Figure 16
<p>Secondary Budd–Chiari syndrome in a patient with a large adrenal carcinoma ((<b>A</b>), contrast-enhanced CT sagittal view, black arrow) complicated by neoplastic thrombosis invading the inferior vena cava with extension to the right atrium ((<b>B</b>), contrast-enhanced CT coronal view, black arrows). In (<b>C</b>), a transverse view shows the hypodense appearance of the thrombus in the IVC (red arrow) and congestion/blood stasis within the hepatic veins (black arrows). Note is made of the parenchymal heterogeneously perfused areas, typical of venous outflow obstruction (arrowheads). On B-mode US the large mass invading the IVC is easily detected in both transverse ((<b>D</b>), white arrow) and coronal views ((<b>E</b>), white arrow). Note is made of small serpiginous vascular channels between the distal segments of the hepatic veins ((<b>E</b>), red arrow) and between the hepatic veins and the venous drainage of the gallbladder ((<b>F</b>), white arrows).</p>
Full article ">Figure 17
<p>Budd–Chiari syndrome secondary to inferior vena cava thrombosis ((<b>A</b>), arrow). Contrast-enhanced ultrasound reveals enhancement of the thrombus in the arterial phase ((<b>B</b>–<b>D</b>), arrows) and subsequent washout in the following vascular phase ((<b>E</b>), arrow) in keeping with neoplastic invasion of the inferior vena cava.</p>
Full article ">Figure 18
<p>Patient with sinusoidal obstruction syndrome post-chemotherapy for breast cancer. The clinical onset was characterized by right upper quadrant pain, jaundice, and abdominal distension secondary to ascites. Blood tests revealed increased transaminase and bilirubin levels, low serum albumin. The MRI demonstrates a liver heterogeneous pattern on the T2W images (<b>A</b>–<b>C</b>) that becomes more pronounced in the arterial phase with multiple hypointense nodules that fade in the portal venous phase (<b>D</b>,<b>E</b>). Note is made of a more diffuse hypointense reticular pattern on the T1W post hepatocyte specific contrast injection (<b>F</b>). The latter is a feature which is highly specific for the diagnosis of sinusoidal obstruction syndrome. Note also the ascites (<b>A</b>–<b>C</b>) and thick-walled gallbladder ((<b>B</b>), white arrow).</p>
Full article ">Figure 19
<p>Contrast-enhanced CT shows a large right lobe hepatocellular carcinoma ((<b>A</b>), asterisk) with portal vein invasion ((<b>A</b>), black arrow) and an arterio-portal fistula ((<b>B</b>), black arrow). Ultrasound color Doppler shows intra-portal aliasing with turbulent arterial high peak systolic velocities as well as high diastolic velocities in keeping with an arterio-portal fistula (<b>C</b>). Contrast-enhanced ultrasound highlights the site of the fistula (white arrows) and early arterial enhancement of the portal vein as a result of the shunt (<b>D</b>–<b>F</b>).</p>
Full article ">Figure 20
<p>There is a small round anechoic area that resembles a simple cyst in segment VII ((<b>A</b>), white arrow). The use of color Doppler reveals that the rounded anechoic area is vascular and actually the point of aberrant connection between the right hepatic vein and the right portal vein branches ((<b>B</b>), white arrow). The Doppler signal highlights the turbulence of the mixed flow at the site of the vascular aberrant communication ((<b>C</b>), white arrow).</p>
Full article ">Figure 21
<p>A 70-year-old was found clinically encephalopathic, with high levels of ammonia. No signs of chronic liver disease, but convoluted serpiginous vascular channels at the point of confluence between the left portal venous branch and the left hepatic vein are evident (arrows). Findings are compatible with a congenital intrahepatic portal systemic shunt between the left branch of the portal vein and the left hepatic vein. Contrast enhanced CT shows the portal-venous shunt from its more proximal to its distal venous portion ((<b>A</b>–<b>C</b>), white arrows). Color Doppler was useful to corroborate these findings (<b>D</b>–<b>F</b>) and follow-up until embolization was achieved.</p>
Full article ">Figure 22
<p>Patient with hereditary haemorrhagic telangiectasia and liver involvement. Note is made of a large area of diffuse heterogeneous enhancement on the arterial phase of this contrast-enhanced CT (<b>A</b>,<b>B</b>). There is also an irregular outline that resembles chronic liver disease (‘pseudocirrhotic pattern’) (<b>A</b>). On ultrasound, a heterogeneous echotexture is present with a patchy echogenic pattern and pseudonodularities in keeping with heterogeneous perfusional areas owing to the marked arterialized parenchyma (<b>C</b>,<b>D</b>). Pronounced arterial hypertrophy can also be noted with a typical double channel appearance (<b>E</b>) and high peak systolic velocities &gt; 80 cm/s (<b>F</b>).</p>
Full article ">
14 pages, 713 KiB  
Review
The Role of Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Diseases
by Ancuța Năstac, Alexandru Constantinescu, Octavian Andronic, Dan Nicolae Păduraru, Alexandra Bolocan and Bogdan Silviu Ungureanu
Gastroenterol. Insights 2024, 15(4), 1014-1027; https://doi.org/10.3390/gastroent15040070 - 27 Nov 2024
Viewed by 284
Abstract
The integration of artificial intelligence (AI) into healthcare, particularly in the field of gastroenterology, marks a significant advancement in the diagnosis and treatment of pancreatic disorders. This narrative review explores the application of AI in enhancing Endoscopic Ultrasound (EUS) imaging techniques for pancreatic [...] Read more.
The integration of artificial intelligence (AI) into healthcare, particularly in the field of gastroenterology, marks a significant advancement in the diagnosis and treatment of pancreatic disorders. This narrative review explores the application of AI in enhancing Endoscopic Ultrasound (EUS) imaging techniques for pancreatic pathologies, focusing on developments over the past decade. Through a comprehensive literature search across several scientific databases, including PubMed, Google Scholar, and Web of Science, this paper selects and analyzes 50 studies that highlight the role, benefits, precision rates, and limitations of AI in EUS. The findings suggest that AI not only improves the quality of endoscopic procedures, as acknowledged by a majority of gastroenterologists in the UK and USA, but also offers a promising future for medical diagnostics and treatment, potentially addressing the shortage of specialists and reducing morbidity and mortality rates. Despite AI’s infancy in clinical applications and the ethical concerns regarding data privacy, its integration into EUS has enhanced diagnostic accuracy and provided minimally invasive therapeutic alternatives. This review underscores the necessity for further clinical data to evaluate the applicability and reliability of AI in healthcare, advocating for a collaborative approach between physicians and AI technologies to revolutionize the traditional clinical diagnosis and expand treatment possibilities in gastroenterology. Full article
(This article belongs to the Section Gastrointestinal and Hepato-Biliary Imaging)
Show Figures

Figure 1

Figure 1
<p>Search strategy.</p>
Full article ">Figure 2
<p>General summary of advantages and disadvantages of AI.</p>
Full article ">
17 pages, 753 KiB  
Systematic Review
The Role of 11C-Methionine PET Imaging for the Evaluation of Lymphomas: A Systematic Review
by Francesco Dondi, Maria Gazzilli, Gian Luca Viganò, Antonio Rosario Pisani, Cristina Ferrari, Giuseppe Rubini and Francesco Bertagna
Hematol. Rep. 2024, 16(4), 752-768; https://doi.org/10.3390/hematolrep16040072 - 27 Nov 2024
Viewed by 302
Abstract
Background: In the last years, different evidence has underlined a possible role for [11C]-methionine ([11C]MET) positron emission tomography (PET) imaging for the evaluation of lymphomas. The aim of this paper was, therefore, to review the available scientific literature focusing on this topic. [...] Read more.
Background: In the last years, different evidence has underlined a possible role for [11C]-methionine ([11C]MET) positron emission tomography (PET) imaging for the evaluation of lymphomas. The aim of this paper was, therefore, to review the available scientific literature focusing on this topic. Methods: A wide literature search of the PubMed/MEDLINE, Scopus and Cochrane Library databases was conducted in order to find relevant published articles investigating the role of [11C]MET in the assessment of lymphomas. Results: Eighteen studies were included in the systematic review and the main fields of application of this imaging modality were the evaluation of disease, therapy response assessment, prognostic evaluation and differential diagnosis with other pathological conditions. Conclusion: Even with heterogeneous evidence, a possible role for [11C]MET PET imaging in the assessment of lymphomas affecting both the whole body and the central nervous system was underlined. When compared to [18F]fluorodesoxyglucose ([18F]FDG) imaging, in general, similar results have been reported between the two modalities in these settings. Full article
Show Figures

Figure 1

Figure 1
<p>Flowchart of the research of eligible studies evaluating the role of [11C]MET PET imaging in the assessment of lymphomas.</p>
Full article ">Figure 2
<p>QUADAS-2 quality assessment for risk of bias and applicability concerns for the studies considered in the review.</p>
Full article ">
15 pages, 7110 KiB  
Case Report
Absorbable Haemostatic Artefacts as a Diagnostic Challenge in Postoperative Follow-Up After Oncological Resection in Head and Neck Tumours: Systematic Review of Current Literature and Two Case Reports
by Giorgio Barbera, Guido Lobbia, Federica Ghiozzi, Alessandra Rovescala, Carlotta Franzina, Sokol Sina and Riccardo Nocini
Diagnostics 2024, 14(23), 2667; https://doi.org/10.3390/diagnostics14232667 - 27 Nov 2024
Viewed by 255
Abstract
Objectives: This article aims to define the clinical, radiological, and pathological characteristics of non-resorbed oxidised cellulose-induced pseudotumours to raise awareness among surgeons and radiologists, to prevent misdiagnosis, and avoid unnecessary invasive procedures and delays in adjuvant oncological treatments. Methods: A systematic [...] Read more.
Objectives: This article aims to define the clinical, radiological, and pathological characteristics of non-resorbed oxidised cellulose-induced pseudotumours to raise awareness among surgeons and radiologists, to prevent misdiagnosis, and avoid unnecessary invasive procedures and delays in adjuvant oncological treatments. Methods: A systematic review of oxidised resorbable cellulose (ORC)-induced pseudotumours of the head and neck was conducted following PRISMA 2020 guidelines. Articles were retrieved from PubMed, Scopus, Cochrane, and Web of Science. Two ORC-induced pseudotumour cases from the Maxillofacial Surgery Department of Verona are also presented. Results: In most cases, pseudotumours were monitored using ultrasound. Further investigations included CT, MRI, PET-CT, and scintigraphy. Ultrasound images showed stable, elongated, and non-homogeneous masses. In CT scans, pseudotumours showed a liquefied core, and none or only peripheral enhancement. In MRI, pseudotumours presented none or only peripheral enhancement, and a heterogeneous pattern in T2-weighted images. 18-FDG PET scans demonstrated an FDG-avid mass (SUV 7.5). Scintigraphy was inconclusive. Cytology indicated a granulomatous reaction without neoplastic cells. Where surgical excision was performed, a granulomatous reaction with the presence of oxidised cellulose fibres was confirmed. Conclusions: Surgeons should consider artifacts from retained oxidised absorbable haemostatic material when suspecting tumour recurrence or metastasis on postoperative imaging, especially if certain features are present. Fine-needle aspiration cytology (FNAC) is a useful diagnostic tool, but surgical excision may be needed if FNAC is inconclusive or impractical. Collaboration between surgeons and radiologists is essential to avoid misdiagnosis and delays in treatment. Documenting the use and location of haemostatic material in operative reports would aid future understanding of these phenomena. Full article
(This article belongs to the Special Issue Advances in Diagnosis and Treatment in Otolaryngology)
Show Figures

Figure 1

Figure 1
<p>Case 1 CT scan with CE, coronal and axial view. Retained ORC pseudotumour is indicated by the arrow.</p>
Full article ">Figure 2
<p>Case 1, 18-FDG PET CT, coronal, sagittal, and axial view. Retained ORC pseudotumour is indicated by the arrow.</p>
Full article ">Figure 3
<p>Case 1: (<b>A</b>) Cytologic slide, Papanicolaou stain, (<b>B</b>) Abundant necrotic debris, Papanicolaou stain, 4×; (<b>C</b>) Abundant necrotic debris, Papanicolaou stain, 20×; (<b>D</b>) Detail of the rare histiocytes, Papanicolaou stain, 40×.</p>
Full article ">Figure 4
<p>Case 1 MRI, T1 with CE, coronal and axial view. Retained ORC pseudotumour is indicated by the arrow.</p>
Full article ">Figure 5
<p>Case 2 MRI, T1 with CE, coronal and axial view. Retained ORC pseudotumour is indicated by the arrow.</p>
Full article ">Figure 6
<p>Case 2: (<b>A</b>) Fragments from the mass removed, haematoxylin-eosin, 4×; (<b>B</b>) Fibrous tissue with chronic inflammation and abundant exogenous material; haematoxylin-eosin, 15×; (<b>C</b>) Detail of the histiocytic–macrophagic elements and multinucleated giant cells, haematoxylin-eosin, 40×; (<b>D</b>) In immunohistochemistry specimen, 2×.</p>
Full article ">Figure 7
<p>PRISMA 2020 flow diagram for papers selection.</p>
Full article ">
13 pages, 808 KiB  
Article
Coincidence of Concentric Vessel-Wall Contrast Enhancement in Moyamoya Disease and Acute Postoperative Ischemic Stroke During Revascularization Procedures
by Patrick Haas, Till-Karsten Hauser, Lucas Moritz Wiggenhauser, Leonie Zerweck, Marcos Tatagiba, Nadia Khan and Constantin Roder
Brain Sci. 2024, 14(12), 1190; https://doi.org/10.3390/brainsci14121190 - 26 Nov 2024
Viewed by 185
Abstract
Background: Concentric vessel-wall contrast enhancement (VW-CE) of the terminal carotid artery and its proximal branches may be linked to ischemic strokes, disease activity and progression in Moyamoya disease (MMD). The objective of this retrospective cohort study is to analyze the association between VW-CE [...] Read more.
Background: Concentric vessel-wall contrast enhancement (VW-CE) of the terminal carotid artery and its proximal branches may be linked to ischemic strokes, disease activity and progression in Moyamoya disease (MMD). The objective of this retrospective cohort study is to analyze the association between VW-CE and perioperative acute ischemic stroke (PAIS) occurring within 24 h after revascularization. Methods: All previously untreated MMD patients who required revascularization and who had undergone preoperative MRI with VW-CE-sequences were included. PAIS was detected by CT and/or diffusion-weighted MRI sequences within 24 h postoperatively. Results: Of the 110 patients included (female-to-male ratio: 2.7:1, median age: 45.1 (16.6–69.2); n = 247 revascularizations), a priori VW-CE was present in 67.3% (mean time from MRI to first surgery: 86 days ± 82 days). PAIS occurred in five patients undergoing primary revascularization (PAIS rate per revascularization: 2.1%), all of whom had a preoperative pathological VW-CE in the vascular segment corresponding to the stroke area. Two (40%) incidents of PAIS occurred in revascularized territory, while three (60%) occurred in non-revascularized vascular territory. In each case, the supplying artery exhibited VW-CE, indicating disease activity. No additional PAIS occurred during subsequent revascularizations in cases of multistage procedures (n = 38), such as ACA or PCA revascularization as a second step. Conclusion: Preoperative VW-CE in one or more vascular segments may be a marker for postoperative stroke in the respective vascular territory at the time of revascularization. VW-CE imaging should be routinely performed when planning revascularization in MMD. If VW-CE is found, strict perioperative monitoring of these high-risk patients should be performed to achieve the best results possible. Full article
11 pages, 3017 KiB  
Review
Anatomy and Pathologies of the Spinous Process
by Sisith Ariyaratne, Nathan Jenko, Karthikeyan P. Iyengar, Mark Davies, Christine Azzopardi, Simon Hughes and Rajesh Botchu
Diseases 2024, 12(12), 302; https://doi.org/10.3390/diseases12120302 - 26 Nov 2024
Viewed by 394
Abstract
The spinous processes act as a lever for attachments of muscles and ligaments. Spinal imaging is commonly performed as a diagnostic test for pain and radiculopathy. A myriad of incidental or unexpected findings, both potentially asymptomatic and symptomatic, may be encountered during the [...] Read more.
The spinous processes act as a lever for attachments of muscles and ligaments. Spinal imaging is commonly performed as a diagnostic test for pain and radiculopathy. A myriad of incidental or unexpected findings, both potentially asymptomatic and symptomatic, may be encountered during the interpretation of these images, which commonly comprise radiographs, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). Isolated lesions of the spinous process, although less common, are some of the lesions that may be encountered and can present a diagnostic dilemma. These can range from congenital abnormalities, traumatic lesions, neoplasms and lesions of inflammatory, infective and metabolic aetiology. The literature specifically reviewing these lesions is sparse. The article reviews a range of pathologies affecting the spinous process, along with their pertinent imaging features, based on isolated pathologies of spinous process lesions identified on imaging by the authors at a tertiary orthopaedic centre over a 10-year period. A search on the hospital Picture Archive and Communication System (PACS) and Radiology Information System (RIS) was performed using the keyword “spinous process” and a list of the isolated pathologies of the spinous process based on the imaging reports was compiled for the purpose of this narrative review. It is important that radiologists consider these lesions when they are identified on routine imaging of the spine. Full article
Show Figures

Figure 1

Figure 1
<p>Sagittal STIR (short tau inversion recovery) image demonstrating Baastrup disease of lumber spinous processes (white arrow). Note the presence of reactive marrow oedema and sclerosis at the opposing surfaces of the spinous processes involved.</p>
Full article ">Figure 2
<p>Sagittal STIR (<b>a</b>) and CT (<b>b</b>) images demonstrating a thoracic spinous process osteoid osteoma (white arrows). Note the presence of reactive marrow oedema on the STIR sequence. The sclerotic reactive bone is well delineated on CT, although the lucent nidus may not always be present as in this case.</p>
Full article ">Figure 3
<p>Sagittal T2 (<b>a</b>), T1 (<b>b</b>) and STIR (<b>c</b>) images showing an osteochondroma of the L5 spinous process (white arrows). Note the presence of the thin cartilage cap on its superior aspect.</p>
Full article ">Figure 4
<p>Sagittal T2 (<b>a</b>), axial T2 (<b>b</b>) and axial CT (<b>c</b>) images demonstrating an aneurysmal bone cyst of a cervical spinous process (white arrows). Note the lytic osseous destruction on CT and the characteristic presence of fluid–fluid levels on MRI.</p>
Full article ">Figure 5
<p>Sagittal T1 (<b>a</b>) and T2 (<b>b</b>) MRI images demonstrating a thoracic spinous process haemangioma (white arrows). Note the presence of high T1 and T2 signals, which are characteristic of a typical haemangioma due to the fat content.</p>
Full article ">Figure 6
<p>Sagittal T1 (<b>a</b>), T2 (<b>b</b>) and CT (<b>c</b>) images of a sclerotic myelomatous deposit involving a thoracic spinous process (white arrows). While myeloma typically tends to present as lytic lesions, occasionally they can be expansile and sclerotic as seen here.</p>
Full article ">Figure 7
<p>Sagittal STIR (<b>a</b>), T1 (<b>b</b>) and CT (<b>c</b>) images demonstrating an eosinophilic granuloma of a thoracic spinous process (white arrows) in a paediatric patient. The lytic appearance is typical of these lesions.</p>
Full article ">Figure 8
<p>Sagittal CT image demonstrating a non-united fracture of C2 spinous process (white arrow).</p>
Full article ">Figure 9
<p>Sagittal (<b>a</b>) and axial (<b>b</b>) STIR sequences demonstrating osteomyelitis of the L4 spinous process, characterised by extensive marrow oedema (white arrow). The oedema also extends to the adjacent laminae in this case, and there is signal change in the adjacent paraspinal muscles, which is a common feature.</p>
Full article ">
19 pages, 4339 KiB  
Article
VDMNet: A Deep Learning Framework with Vessel Dynamic Convolution and Multi-Scale Fusion for Retinal Vessel Segmentation
by Guiwen Xu, Tao Hu and Qinghua Zhang
Bioengineering 2024, 11(12), 1190; https://doi.org/10.3390/bioengineering11121190 - 25 Nov 2024
Viewed by 337
Abstract
Retinal vessel segmentation is crucial for diagnosing and monitoring ophthalmic and systemic diseases. Optical Coherence Tomography Angiography (OCTA) enables detailed imaging of the retinal microvasculature, but existing methods for OCTA segmentation face significant limitations, such as susceptibility to noise, difficulty in handling class [...] Read more.
Retinal vessel segmentation is crucial for diagnosing and monitoring ophthalmic and systemic diseases. Optical Coherence Tomography Angiography (OCTA) enables detailed imaging of the retinal microvasculature, but existing methods for OCTA segmentation face significant limitations, such as susceptibility to noise, difficulty in handling class imbalance, and challenges in accurately segmenting complex vascular morphologies. In this study, we propose VDMNet, a novel segmentation network designed to overcome these challenges by integrating several advanced components. Firstly, we introduce the Fast Multi-Head Self-Attention (FastMHSA) module to effectively capture both global and local features, enhancing the network’s robustness against complex backgrounds and pathological interference. Secondly, the Vessel Dynamic Convolution (VDConv) module is designed to dynamically adapt to curved and crossing vessels, thereby improving the segmentation of complex morphologies. Furthermore, we employ the Multi-Scale Fusion (MSF) mechanism to aggregate features across multiple scales, enhancing the detection of fine vessels while maintaining vascular continuity. Finally, we propose Weighted Asymmetric Focal Tversky Loss (WAFT Loss) to address class imbalance issues, focusing on the accurate segmentation of small and difficult-to-detect vessels. The proposed framework was evaluated on the publicly available ROSE-1 and OCTA-3M datasets. Experimental results demonstrated that our model effectively preserved the edge information of tiny vessels and achieved state-of-the-art performance in retinal vessel segmentation across several evaluation metrics. These improvements highlight VDMNet’s superior ability to capture both fine vascular details and overall vessel connectivity, making it a robust solution for retinal vessel segmentation. Full article
(This article belongs to the Section Biosignal Processing)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The architecture of VDMNet, which is composed of encoder, decoder, and skip connections.</p>
Full article ">Figure 2
<p>The proposed Fast Multi-Head Self-Attention Mechanism. (<b>a</b>) Fast Multi-Head Self-Attention Mechanism encoder. (<b>b</b>) Fast Multi-Head Self-Attention Mechanism decoder. They share similar concepts, but (<b>b</b>) takes two inputs: the high-resolution features from skip connections in the encoder and the low-resolution features from the decoder.</p>
Full article ">Figure 3
<p>Multi-Scale Fusion Module.</p>
Full article ">Figure 4
<p>Retinal vessel segmentation results of the proposed VDMNet and other segmentation networks. From top to bottom, the OCTA images of rows 1 and 3 come from ROSE-1, and rows 5 and 7 come from OCTA-3M, respectively. Rows 2, 4, 6, and 8 show the corresponding locally zoomed-in OCTA images, as well as the ground truth and segmentation results.</p>
Full article ">
13 pages, 3041 KiB  
Article
Detection of Disease Features on Retinal OCT Scans Using RETFound
by Katherine Du, Atharv Ramesh Nair, Stavan Shah, Adarsh Gadari, Sharat Chandra Vupparaboina, Sandeep Chandra Bollepalli, Shan Sutharahan, José-Alain Sahel, Soumya Jana, Jay Chhablani and Kiran Kumar Vupparaboina
Bioengineering 2024, 11(12), 1186; https://doi.org/10.3390/bioengineering11121186 - 25 Nov 2024
Viewed by 533
Abstract
Eye diseases such as age-related macular degeneration (AMD) are major causes of irreversible vision loss. Early and accurate detection of these diseases is essential for effective management. Optical coherence tomography (OCT) imaging provides clinicians with in vivo, cross-sectional views of the retina, enabling [...] Read more.
Eye diseases such as age-related macular degeneration (AMD) are major causes of irreversible vision loss. Early and accurate detection of these diseases is essential for effective management. Optical coherence tomography (OCT) imaging provides clinicians with in vivo, cross-sectional views of the retina, enabling the identification of key pathological features. However, manual interpretation of OCT scans is labor-intensive and prone to variability, often leading to diagnostic inconsistencies. To address this, we leveraged the RETFound model, a foundation model pretrained on 1.6 million unlabeled retinal OCT images, to automate the classification of key disease signatures on OCT. We finetuned RETFound and compared its performance with the widely used ResNet-50 model, using single-task and multitask modes. The dataset included 1770 labeled B-scans with various disease features, including subretinal fluid (SRF), intraretinal fluid (IRF), drusen, and pigment epithelial detachment (PED). The performance was evaluated using accuracy and AUC-ROC values, which ranged across models from 0.75 to 0.77 and 0.75 to 0.80, respectively. RETFound models display comparable specificity and sensitivity to ResNet-50 models overall, making it also a promising tool for retinal disease diagnosis. These findings suggest that RETFound may offer improved diagnostic accuracy and interpretability for specific tasks, potentially aiding clinicians in more efficient and reliable OCT image analysis. Full article
(This article belongs to the Special Issue AI in OCT (Optical Coherence Tomography) Image Analysis)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Examples of labeled OCT B-scans for drusen, pigment epithelial detachment, intraretinal fluid, subretinal fluid, hyperreflective dots, and hyperreflective foci.</p>
Full article ">Figure 2
<p>Main page of OCT image-labeling software created and used for labeling OCT scans.</p>
Full article ">Figure 3
<p>Interactive window pop-up of OCT scan used to label a single scan.</p>
Full article ">Figure 4
<p>(<b>a</b>) Schematic of RETFound model and (<b>b</b>) model for down-stream task of labeling pathologic features on OCT scans based on RETFound.</p>
Full article ">Figure 5
<p>Schematic of the ResNet-50 model trained on the task of labeling pathologic features on OCT scans.</p>
Full article ">
16 pages, 1725 KiB  
Article
Unlocking Chemotherapy Success: The Role of Diffusion Tensor Imaging in Breast Cancer Treatment
by Anca Ileana Ciurea, Ioana Bene, Paul Cheregi, Thea Brad, Cristiana Augusta Ciortea, Georgeta Mihaela Rusu, Larisa Dorina Ciule, Andrada-Larisa Deac and Manuela Lavinia Lenghel
Diagnostics 2024, 14(23), 2650; https://doi.org/10.3390/diagnostics14232650 - 24 Nov 2024
Viewed by 399
Abstract
Background: This study investigates the role of Diffusion Tensor Imaging (DTI) in predicting the response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer. Methods: A Diffusion Tensor Imaging magnetic resonance imaging (DTI MRI) sequence, evaluating water diffusion along tissue structures, [...] Read more.
Background: This study investigates the role of Diffusion Tensor Imaging (DTI) in predicting the response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer. Methods: A Diffusion Tensor Imaging magnetic resonance imaging (DTI MRI) sequence, evaluating water diffusion along tissue structures, was performed before and after two chemotherapy cycles. This study included 23 patients with 27 malignant masses, comparing changes in DTI parameters with Residual Cancer Burden (RCB) scores. Results: We found a significant correlation between changes in specific DTI parameters (e.g., λ2, FA, RA) and pathological response, suggesting that DTI could serve as a sensitive marker for early chemotherapy response. However, differences in sensitivity were observed between DTI sequences with 6 and 12 directions, indicating that 12-direction DTI may provide better diagnostic accuracy. The percentage change in DTI parameters, particularly FA, demonstrated a strong ability to predict pathological complete response (pCR) with high sensitivity. Conclusions: As a non-invasive tool, DTI has the potential to assess chemotherapy efficacy, although larger studies with standardized protocols are necessary to validate its clinical utility. Full article
(This article belongs to the Special Issue Advances in Breast Radiology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Scatter plots suggesting the association between RCB class and percent change between examinations in 6-direction DTI parameters: λ2 (<b>left</b>) and FA (<b>right</b>). The blue line indicates the liniar regresion line with a confindence interval of 95% and the dots indicate the data point.</p>
Full article ">Figure 2
<p>Scatter plots suggesting the association between RCB class and percent change between examinations of the 12-direction DTI parameters: λ1 (<b>left</b>) and RA (<b>right</b>). The blue line indicates the liniar regresion line with a confindence interval of 95% and the dots indicate the data point.</p>
Full article ">Figure 3
<p>Boxplots showing the percentage change between examinations of 6-way DTI parameters for RCB 0 and non-RCB non subgroups. Statistical analysis of differences between subgroups was performed with Student’s <span class="html-italic">t</span> test for independent variables (for normally distributed variables) and the Mann–Whitney U test (for non-normally distributed variables). Statistical significance was obtained for λ2 (<span class="html-italic">p</span> = 0.029), and there was a trend towards significance for FA (<span class="html-italic">p</span> = 0.092). <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>b</sup> <span class="html-italic">p</span> &lt; 0.1.</p>
Full article ">Figure 4
<p>Boxplots showing, for RCB 0 and non-RCB 0 subgroups, the percentage change between examinations in 12-direction DTI parameters. Statistical analysis of differences between subgroups was performed with Student’s <span class="html-italic">t</span> test for independent variables (for normally distributed variables) and the Mann–Whitney U test (for non-normally distributed variables). <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>b</sup> <span class="html-italic">p</span> &lt; 0.1.</p>
Full article ">Figure 5
<p>ROC analysis of the use of percentage changes in 6-direction DTI parameters to identify patients who would achieve a pathological complete response following NAC. ROC curves of DTI parameters for which AUC ≥ 0.5 and <span class="html-italic">p</span> ≤ 0.05 (<span class="html-italic">p</span> value was obtained with the DeLong test) were plotted: FA (AUC = 0.72 ± 0.10; <span class="html-italic">p</span> = 0.016) and λ2 (AUC = 0.72 ± 0.12; <span class="html-italic">p</span> = 0.038). To compare the two curves, the DeLong test was applied, and it showed that there were no statistically significant differences between the curves (<span class="html-italic">p</span> = 0.963).</p>
Full article ">Figure 6
<p>ROC analysis of using percentage changes in 12-direction DTI parameters to identify patients who would achieve a pathologic complete response following NAC. ROC curves of DTI parameters for which AUC ≥ 0.5 and <span class="html-italic">p</span> ≤ 0.05 (<span class="html-italic">p</span> value was obtained with the DeLong test) were plotted: FA (AUC = 0.75 ± 0.11; <span class="html-italic">p</span> = 0.012), RA (AUC = 0.83 ± 0.08; <span class="html-italic">p</span> = 0.001) and λ1–λ3 (AUC = 0.75 ± 0.09; <span class="html-italic">p</span> = 0.004). To compare the curves between them, the DeLong test was applied, and it revealed no statistically significant differences between the parameters.</p>
Full article ">
22 pages, 1508 KiB  
Review
Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by Ewelina Młynarska, Ewa Radzioch, Bartłomiej Dąbek, Klaudia Leszto, Alicja Witkowska, Witold Czarnik, Weronika Jędraszak, Jacek Rysz and Beata Franczyk
Biomedicines 2024, 12(12), 2675; https://doi.org/10.3390/biomedicines12122675 - 24 Nov 2024
Viewed by 422
Abstract
Hypertrophic cardiomyopathy (HCM) is a heterogeneous group of heart muscle disorders that affects millions, with an incidence from 1 in 500 to 1 in 200. Factors such as genetics, age, gender, comorbidities, and environmental factors may contribute to the course of this disease. [...] Read more.
Hypertrophic cardiomyopathy (HCM) is a heterogeneous group of heart muscle disorders that affects millions, with an incidence from 1 in 500 to 1 in 200. Factors such as genetics, age, gender, comorbidities, and environmental factors may contribute to the course of this disease. Diagnosis of HCM has improved significantly in the past few decades from simple echocardiographic evaluations to a more complex, multimodal approach embracing advanced imaging, genetic, and biomarker studies. This review focuses on Mavacamten, a selective allosteric inhibitor of cardiac myosin, as a pharmacological treatment for HCM. Patients with HCM experience pathological actomyosin interactions, leading to impaired relaxation and increased energy expenditure. Mavacamten decreases available myosin heads, reducing actomyosin cross-bridges during systole and diastole. By reducing the number of bridges left ventricular outflow tract pressure is normalized and cardiac cavities are filled. This mechanism enhances patient performance and alleviates symptoms such as chest pain and dyspnea. The results suggest the potential for Mavacamten to transform the treatment of obstructive hypertrophic cardiomyopathy. Studies to date have shown significant improvement in exercise capacity, symptom relief, and a reduction in the need for invasive procedures such as septal myectomy. Further studies are needed to confirm the clinical results. Full article
Show Figures

Figure 1

Figure 1
<p>Summary of the proposed cardiomyopathy classification system [<a href="#B1-biomedicines-12-02675" class="html-bibr">1</a>]. ARVC indicates arrhythmogenic right ventricular cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; and RCM, restrictive cardiomyopathy.</p>
Full article ">Figure 2
<p>Pathophysiological changes in hypertrophic cardiomyopathy [<a href="#B11-biomedicines-12-02675" class="html-bibr">11</a>]. LVOTO indicates left ventricular outflow track obstruction; HCM, hypertrophic cardiomyopathy.</p>
Full article ">Figure 3
<p>Risk factors of hypertrophic cardiomyopathy [<a href="#B40-biomedicines-12-02675" class="html-bibr">40</a>,<a href="#B42-biomedicines-12-02675" class="html-bibr">42</a>,<a href="#B48-biomedicines-12-02675" class="html-bibr">48</a>,<a href="#B49-biomedicines-12-02675" class="html-bibr">49</a>,<a href="#B50-biomedicines-12-02675" class="html-bibr">50</a>,<a href="#B51-biomedicines-12-02675" class="html-bibr">51</a>,<a href="#B52-biomedicines-12-02675" class="html-bibr">52</a>].</p>
Full article ">Figure 4
<p>Possible adverse reactions occurring during Mavacamten use [<a href="#B120-biomedicines-12-02675" class="html-bibr">120</a>].</p>
Full article ">
9 pages, 3259 KiB  
Review
Lung Cancer Associated with Cystic Airspaces: Current Insights into Diagnosis, Pathophysiology, and Treatment Strategies
by Kun Wang, Xuechun Leng, Hang Yi, Guochao Zhang, Zhongwu Hu and Yousheng Mao
Cancers 2024, 16(23), 3930; https://doi.org/10.3390/cancers16233930 - 24 Nov 2024
Viewed by 404
Abstract
Lung cancer associated with cystic airspaces (LCCA) is a rare subtype of non-small-cell lung cancer (NSCLC), accounting for 1–4% of cases. LCCA is characterized by the presence of cystic airspaces within or at the periphery of the tumor on imaging. LCCA poses significant [...] Read more.
Lung cancer associated with cystic airspaces (LCCA) is a rare subtype of non-small-cell lung cancer (NSCLC), accounting for 1–4% of cases. LCCA is characterized by the presence of cystic airspaces within or at the periphery of the tumor on imaging. LCCA poses significant clinical challenges due to its high risk of misdiagnosis or missed diagnosis, often leading to a worse prognosis compared to other forms of lung cancer. While previous studies have identified correlations between the pathological features and imaging characteristics of LCCA, research on its associated driver gene mutations and responses to chemotherapy and immunotherapy remains limited. Furthermore, the development of an appropriate T-staging system is necessary to improve prognostic outcomes. This review provides an overview of the current research on the definition, imaging classification, pathological and molecular mechanisms, and prognosis of LCCA, aiming to provide a reference for clinical decision-making. Full article
(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
Show Figures

Figure 1

Figure 1
<p>Typical imaging classifications and pathological features of LCCA. (<b>A</b>) Four imaging classifications of LCCA. Type I: thin-walled type; Type II: thick-walled type; Type III: mural nodule type; Type IV: mixed type (each from a different patient). (<b>B</b>) Postoperative pathological findings of LCCA classifications (H&amp;E staining, 10× magnification). Type I: minimally invasive adenocarcinoma; Type II: poorly differentiated invasive adenocarcinoma; Type III: poorly differentiated invasive adenocarcinoma with vascular invasion; Type IV: moderately differentiated invasive adenocarcinoma. (<b>C</b>) Comparison of lung adenocarcinoma subtypes in postoperative LCCA classifications. Type I: minimally invasive adenocarcinoma, predominantly lepidic type; Type II: predominantly papillary-type adenocarcinoma; Type III: predominantly solid-type adenocarcinoma; Type IV: predominantly acinar-type adenocarcinoma.</p>
Full article ">Figure 2
<p>Different progression patterns of LCCA. (<b>A</b>) Enlargement of the cystic cavity during follow-up. (<b>B</b>) An increase in the number of segmented cystic spaces with the addition of ground-glass opacity components in the cyst wall during follow-up. (<b>C</b>) Reduction of the cystic cavity with an increase in solid components in the wall nodules during follow-up. Red arrows indicate lung cancer associated with cystic airspaces.</p>
Full article ">
9 pages, 983 KiB  
Article
Ex Vivo Fluorescence Confocal Microscopy Meets Innovation and Revolutionary Technology, for “Real-Time” Histological Evaluation, in Pediatric Surgical Oncology
by Donatella Di Fabrizio, Edoardo Bindi, Michele Ilari, Alessandra Filosa, Gaia Goteri and Giovanni Cobellis
Children 2024, 11(12), 1417; https://doi.org/10.3390/children11121417 - 23 Nov 2024
Viewed by 415
Abstract
Background and Aim: Ex vivo fluorescence confocal microscopy (FCM) systems are innovative optical imaging tools that create virtual high-resolution histological images without any standard tissue processing, either freezing or fixing in formalin and embedding in paraffin. These systems have opened an era that [...] Read more.
Background and Aim: Ex vivo fluorescence confocal microscopy (FCM) systems are innovative optical imaging tools that create virtual high-resolution histological images without any standard tissue processing, either freezing or fixing in formalin and embedding in paraffin. These systems have opened an era that would revolutionize pathological examination by providing rapid, real-time assessments across various pathology subspecialties, potentially replacing conventional methods that are tissue- and time-consuming. This study aimed to present the first utilization of FCM in pediatric surgical oncology, focusing on assessing the benefits, particularly in facilitating rapid and accurate diagnosis. Methods: This preliminary study comprised five consecutive patients undergoing surgical biopsy for disease characterization and surgical strategy selection. After biopsy, tissue samples were prepared and analyzed using FCM without sectioning. A pathologist who evaluated macroscopic and microscopic images, once obtained remotely, could promptly indicate any interventions that require timeliness. Samples were then evaluated with conventional methods. Results: All five lesions were deemed suitable for evaluation. Preliminary diagnoses utilizing FCM included atypical Spitz nevus (1), Wilm’s tumor (1), lymph node reactive hyperplasia (1), malignant germ cell tumor of the testis (1), and Hodgkin’s lymphoma (1). Final histopathological analyses revealed atypical Spitz nevus (1), Wilm’s tumor (1), hyperplastic lymphadenopathy with a prevalent marginal pattern (1), mixed nonseminomatous malignant germinal neoplasm consisting of embryonal carcinoma (90%) and yolk sac tumor (10%), and Hodgkin’s lymphoma nodular sclerosis variant (1). In the case of diagnosis of atypical Spitz nevus, the widening of the resection margins was performed in the same surgery. In the case of testicular neoplasm, radical orchiectomy was performed. A high level of agreement between FCM evaluation and definitive histological examination was observed for all parameters evaluated. Conclusions: FCM represents a significant advancement in pathological imaging technology, offering potential benefits in enhancing traditional tissue processing methods. This preliminary report marks the first application of FCM in pediatric surgical oncology. Our findings underscore the promising role of FCM as an adjunctive tool in pediatric oncology, facilitating prompt diagnosis and treatment initiation. Full article
(This article belongs to the Special Issue Diagnosis and Surgical Care of Pediatric Cancers)
Show Figures

Figure 1

Figure 1
<p>Skin lesion was excised by pediatric surgeon and the specimen was divided in three sections and colored with fluorescent dyes (<b>A</b>: one section). Vivascope scanned each section of the lesion, and the virtual slides were acquired with different grades of magnification (<b>B</b>–<b>D</b>).</p>
Full article ">Figure 2
<p>Low power slide scan: the lesion was originally cut in three sections, which were examined using confocal microscopy. Then, the same sections were put in the block for processing. The silhouette of the lesion is dermal-based (<b>A</b>). An intermediate power view demonstrates the sparing of the epidermis by the lesion, which showed a well-circumscribed superficial border and a clear-cut margin at the bottom without extending into the ipodermal fat (<b>B</b>,<b>C</b>). Cellular composition of the lesion, characterized by epithelioid plumped cells with wide eosinophilic cytoplasm, along with cytological nuclear details, were perfectly preserved at the definitive staining after confocal microscopy examination (<b>D</b>).</p>
Full article ">
15 pages, 2215 KiB  
Case Report
Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature
by Enes Erul, Ömer Gülpınar, Diğdem Kuru Öz, Havva Berber, Saba Kiremitci and Yüksel Ürün
Medicina 2024, 60(12), 1918; https://doi.org/10.3390/medicina60121918 - 22 Nov 2024
Viewed by 365
Abstract
Background and Objectives: Primary prostatic stromal sarcoma is an exceptionally rare urological malignancy, constituting less than 0.1% of all prostatic cancers. It poses a significant clinical challenge due to its aggressive behavior and poor prognosis. Materials and Methods: We report the [...] Read more.
Background and Objectives: Primary prostatic stromal sarcoma is an exceptionally rare urological malignancy, constituting less than 0.1% of all prostatic cancers. It poses a significant clinical challenge due to its aggressive behavior and poor prognosis. Materials and Methods: We report the case of a 34-year-old male who presented with nonspecific lower urinary tract symptoms, including dysuria and increased urinary frequency. The initial diagnostic workup, including digital rectal examination and Magnetic Resonance Imaging (MRI), revealed a lobulated lesion within the prostate. A transurethral resection (TUR) was performed for diagnostic purposes, and histopathological examination revealed a “malignant mesenchymal tumor”. The patient underwent a laparoscopic radical prostatectomy. The pathology report confirmed the diagnosis of prostatic stromal sarcoma. The postoperative follow-up, including systemic CT and MRI, showed no evidence of recurrence or metastasis thus far. Results: Multidisciplinary management is essential for optimizing treatment outcomes in all urologic malignancies; however, it becomes particularly challenging and crucial in rare cases such as primary prostatic stromal sarcoma. In our case, the patient benefited from a coordinated approach involving urology, pathology, and oncology, underscoring the importance of collaborative care for rare and aggressive tumors like this. This case highlights the importance of early detection, complete surgical excision, and consideration of adjuvant therapies, given the aggressive nature of the disease. The role of novel therapeutic strategies, including immunotherapy and targeted therapies, is also discussed in the context of metastatic sarcomas. Conclusions: This case underscores the critical need for a comprehensive, multidisciplinary approach to managing primary prostatic stromal sarcoma. Ongoing research on innovative therapies offers hope for improved outcomes in metastatic stages. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>–<b>c</b>). In the T2-weighted image (<b>a</b>), a heterogeneous, well-defined, lobulated nodular lesion is observed, confined to the prostate gland, exhibiting marked hyperintense signal characteristics originating from the midline urethral area and largely filling the left lobe of the prostate gland. In the diffusion-weighted image (<b>b</b>) acquired with a b-value of 2000, focal areas of diffusion restriction are observed within the lesion. The lesion demonstrates intense and heterogeneous enhancement in the early arterial phase (<b>c</b>).</p>
Full article ">Figure 2
<p>Histopathological findings of prostatic stromal sarcoma. (<b>A</b>) Invasion of the atypical spindle tumor cells between the metaplastic benign epithelial and glandular structures in a diffuse stromal growth pattern with phyllodes-like and hypercellular areas, ×40, Hematoxylin–Eosin. (<b>B</b>) Hypocellular myxoid areas with round and starry tumor cells, ×100. (<b>C</b>) Increased mitotic activity in high magnification, ×400. (<b>D</b>) Remarkable atypical tripolar mitosis, ×690.</p>
Full article ">Figure 3
<p>Immunohistochemical findings of prostatic stromal sarcoma. Diffuse and strong positivity with Vimentin (×150); focal positivity with CD34 (vascular structures as internal control) (×110); infrequent positivity with PR (×220); diffuse positivity with p53 (×150); high proliferation index with Ki67 (×150).</p>
Full article ">
Back to TopTop